We are live on ! Find out more
BPB

Badgley, Phelps & Bell Portfolio holdings

AUM $2.69B
1-Year Est. Return 41.96%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+41.96%
3 Year Est. Return
+78.28%
5 Year Est. Return
+148.11%
10 Year Est. Return
AUM
$1.24B
AUM Growth
+$84M
Cap. Flow
+$16.4M
Cap. Flow %
1.32%
Top 10 Hldgs %
25.95%
Holding
159
New
8
Increased
74
Reduced
60
Closed
10

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.36M
2
UNH icon
UnitedHealth
UNH
+$9.14M
3
SYK icon
Stryker
SYK
+$6.62M
4
MS icon
Morgan Stanley
MS
+$6.34M
5
CRM icon
Salesforce
CRM
+$4.1M

Sector Composition

Rank Sector Weight
1 Financials 11.57%
2 Healthcare 11.25%
3 Technology 11.07%
4 Consumer Discretionary 6.87%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWI icon
151
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.79B
-12,605
Closed -$265K
DG icon
152
Dollar General
DG
$28.1B
-32,271
Closed -$2.39M
F icon
153
Ford
F
$59.3B
-42,038
Closed -$510K
OXY icon
154
Occidental Petroleum
OXY
$55.6B
-4,740
Closed -$338K
SCHF icon
155
Schwab International Equity ETF
SCHF
$67B
-106,028
Closed -$1.47M
TGT icon
156
Target
TGT
$65.6B
-81,353
Closed -$5.88M
USO icon
157
United States Oil Fund
USO
$2.12B
-1,875
Closed -$176K
XLF icon
158
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
-8,690
Closed -$202K
CERN
159
DELISTED
Cerner Corp
CERN
-138,916
Closed -$6.58M

Similar funds

Badgley, Phelps & Bell's Q1 2017 Portfolio in Review

As of Q1 2017, Badgley, Phelps & Bell held 159 positions worth $1.24B, up 7.3% from $1.15B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Badgley, Phelps & Bell's Q1 2017 filing shows 8 new, 74 increased, 60 reduced and 10 closed positions. Its largest new stake was Eli Lilly: 116,897 shares worth $9.83M. The largest sale was Cerner Corp, an estimated $6.58M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Technology.

  • Badgley, Phelps & Bell's largest Q1 2017 buy was Eli Lilly: 116,897 shares worth $9.83M.
  • Badgley, Phelps & Bell added most to UnitedHealth in Q1 2017, an estimated $9.14M increase.
  • Badgley, Phelps & Bell's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $6.41M.
  • Badgley, Phelps & Bell fully exited Cerner Corp in Q1 2017, selling an estimated $6.58M.
  • Badgley, Phelps & Bell's ten largest holdings make up 26% of its $1.24B portfolio in Q1 2017.
  • Badgley, Phelps & Bell opened 8 new positions and closed 10 in Q1 2017.
  • Badgley, Phelps & Bell's portfolio value rose 7.3% quarter-over-quarter to $1.24B.

Based on Badgley, Phelps & Bell's 13F filing for Q1 2017, filed 15 May 2017.